Patents by Inventor Johannes Jukna

Johannes Jukna has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Xanthines
    Patent number: 5321029
    Abstract: A compound of formula (I): ##STR1## or where appropriate a pharmaceutically acceptable salt thereof, wherein R.sup.1 and R.sup.2 each independently represent a moiety of formula (a):--(CH.sub.2).sub.m --A (a)wherein m represents zero or an integer 1, 2 or 3, A represents a substituted or unsubstituted cyclic hydrocarbon radical; andR.sup.3 represents hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl or a moiety of formula (a) as defined above; a pharmaceutical composition comprising such a compound a process for preparing such a compound and the use of said compound and said composition in medicine.
    Type: Grant
    Filed: January 13, 1992
    Date of Patent: June 14, 1994
    Assignee: Beecham-Wuelfing GmbH & Co.K.G.
    Inventors: Harald Maschler, Rolf T. Wilke, Johannes Jukna
  • Treatment of neuronal degeneration with 5HT1.sub.A agonists
    Patent number: 5162375
    Abstract: A method for the treatment and/or prophylaxis of disorders associated with neuronal degeneration resulting from ischaemic events, in mammals, such as humans, which comprises administering to the mammal in need of such treatment an effective amount of a 5-HT1.sub.A agonist.
    Type: Grant
    Filed: February 28, 1991
    Date of Patent: November 10, 1992
    Assignee: Beecham Group p.l.c.
    Inventors: Charles D. Nicholson, Johannes Jukna
  • Novel treatment for ischemia using an aminotetralin
    Patent number: 5049588
    Abstract: A method for the treatment and/or prophylaxis of disorders associated with neuronal degeneration resulting from ischaemic events, in mammals, such as humans, which comprises administering to the mammal in need of such treatment an effective amount of a 5-HTl.sub.A agonist.
    Type: Grant
    Filed: May 8, 1989
    Date of Patent: September 17, 1991
    Assignee: Beecham Group p.l.c.
    Inventors: Charles D. Nicholson, Johannes Jukna